Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
A post hoc analysis of trial data published in Diabetes Care found that adults with type 2 diabetes receiving tirzepatide ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests. The active drug ...
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...
Hosted on MSN11d
'King Kong' of weight-loss drugs, Mounjaro, will be available in Ireland from next weekUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...
Tirzepatide will be available at pharmacies in Ireland initially in doses of 2.5 mg and 5 mg, with availability of higher doses expected in the coming months. Tirzepatide is administered ...
This Feature (BMJ 2025;388:q2636, doi:10.1136/bmj.q2636, published 3 February 2025) stated that the NICE guidance on tirzepatide was still in draft form. In fact ...
CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback